FindTrial
Sign In

Real-time Continuous Cardiac Output Measurements

Real-time Automatic Continuous Cardiac Output Measurements Using Transthoracic Echocardiography (TTE) in ICU-patients in Comparison to Flotrac Measurements

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04774978
Enrollment
20
Registered
2021-03-01
Start date
2021-03-01
Completion date
2022-07-01
Last updated
2021-03-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Output, Low

Keywords

Cardiac output, TTE

Brief summary

Study to assess the feasibility of real-time automatic cardiac output measurements using transthoracic echocardiography (TTE)

Detailed description

Rationale: Study to assess the feasibility of real-time automatic cardiac output measurements using transthoracic echocardiography (TTE) Objective: To assess the correlation and feasibility of real-time automatic continuous cardiac output measurements using transthoracic ultrasound (TTE) in adult ICU-patients in comparison to Flotrac measurements Study design: prospective, feasibility study Study population: Adult Intensive Care patients ( \> 18 years) Intervention (if applicable): Consecutive adult patients on the ICU in which the there is an indication for continuous cardiac output measurements. Main study parameters/endpoints: * Percentage of patients in which continuous cardiac output can be measured using TTE * Correlation between continuous TTE and Flotrac measurements

Interventions

DEVICETTE

Transthoracic echocardiography

Sponsors

Rijnstate Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult Intensive Care patients ( \> 18 years)

Exclusion criteria

* Pregnancy * Atrial fibrillation or other irregular heart rhythm

Design outcomes

Primary

MeasureTime frameDescription
Patients in which the ProbeFix can be used continuously2 monthsPercentages will be reported

Secondary

MeasureTime frameDescription
Correlation between continuous TTE and Flotrac2 monthsBland-Altman plot will be reported

Contacts

Primary ContactB Baten
BBaten@rijnstate.nl088 - 0057870

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026